Zacks Research has raised its Q2 2026 earnings estimate for Devon Energy (NYSE:DVN) to $1.25 per share from $1.04, while maintaining a "Hold" rating. The firm also increased its earnings forecasts for fiscal years 2026 through 2028. This update comes despite Devon Energy recently missing quarterly earnings expectations, though the company did boost its quarterly dividend.

Zacks Research has increased its Q2 2026 EPS estimate for Diamondback Energy (NASDAQ:FANG) to $5.20 from $4.96, while maintaining a "Hold" rating. Despite this, several other analysts are more bullish, giving the stock ratings such as "Overweight," "Strong Buy," and "Outperform," with a consensus target price of $223.26. The company recently surpassed earnings expectations, reporting $4.23 EPS on $4.24 billion in revenue, and also increased its quarterly dividend to $1.10 per share.

Bespin Global has secured the "AI Research Environment Operations" project with Woori Financial Group, aiming to establish a secure and flexible environment for testing and utilizing AI technologies within the financial sector. They plan to build an independent AWS-based architecture using their "HelpNow AI Foundry" platform, enabling safe experimentation with advanced AI, including generative AI and LLMs, under strict network separation regulations. This collaboration seeks to accelerate AI transformation for financial institutions while ensuring security and regulatory compliance.

Trinseo PLC and its affiliates have filed for Chapter 11 bankruptcy with plans for a prepackaged restructuring to cut approximately $2.0 billion in debt. The plan features new financing, an equity raise, and distinct recoveries for creditors based on their position within two collateral silos. One creditor, CastleKnight Management LP, is objecting to the plan’s confirmation, citing low recovery on its OpCo term loans.

Melius Research analysts have slightly cut their Q4 2026 EPS estimate for Huntington Ingalls Industries (HII) to $4.95 from $5.05, despite the company recently beating Q1 expectations. HII's latest quarterly results showed EPS of $3.79 on revenues of $3.10 billion, both exceeding analyst forecasts. Despite some positive sentiment from other analysts regarding future earnings, HII currently holds an average "Hold" rating with an average price target of $388.50, and its stock is trading below recent moving averages, reflecting investor caution.

Amcor plc (AMCR, AMC) experienced steady trading on the NYSE and ASX, with investors primarily focused on its attractive dividend yield and stable cash flows rather than new company filings. The company, a major player in packaging for consumer and healthcare goods, is viewed as a defensive income stock due to its consistent performance and lack of recent significant news or analyst updates. Its core business model, centered on long-term relationships with global clients, underpins its reliable income profile.

UCB and Biogen announced the publication of positive Phase 3 study results for dapirolizumab pegol (DZP) in The Lancet, demonstrating its efficacy in treating moderate-to-severe active systemic lupus erythematosus (SLE). The PHOENYCS GO trial showed statistically significant improvement in disease activity with DZP plus standard of care, along with a favorable safety profile and glucocorticoid-sparing effect. These results support the continued development of DZP, with a confirmatory Phase 3 study (PHOENYCS FLY) currently recruiting patients.

UCB and Biogen announced the publication of positive Phase 3 study results for dapirolizumab pegol (DZP) in The Lancet, demonstrating significant improvement in disease activity for patients with moderate-to-severe systemic lupus erythematosus (SLE). The PHOENYCS GO trial met its primary endpoint, showing a higher proportion of patients treated with DZP plus standard of care achieved BICLA response at Week 48, along with favorable safety profiles and glucocorticoid-sparing effects. These results support the ongoing confirmatory Phase 3 PHOENYCS FLY trial, highlighting DZP's potential as a new treatment option for SLE.

General Electric Co (GE Aerospace) shares remained firm in New York after reporting strong first-quarter results and maintaining its prominent position in major U.S. equity benchmarks. The stock traded around USD 323 on the NYSE, reflecting its large-cap status and the market's focus on its aviation-centric business model. The company's performance is now closely linked to global air travel demand and defense spending.

Cadence (Nasdaq: CDNS) announced the industry's first fully autonomous virtual agentic AI design engineer, extending its ChipStack™ AI Super Agent to Level-5 autonomy at Computex 2026. Powered by NVIDIA Nemotron models and secured by NVIDIA OpenShell runtime, this innovation dramatically accelerates RTL validation cycles by over 40x, reducing typical five-week verification loops to less than a day. The technology allows engineers to supervise outcomes while the AI autonomously handles complex chip design and verification workflows.